Overview

A Study to Investigate the Relative Bioavailability of Entrectinib Capsule Formulations F1 and F06 Under Fed Conditions in Healthy Participants

Status:
Completed

Trial end date:
2019-02-04

Target enrollment:

Participant gender:

Summary

This study aims to investigate the relative bioavailability, safety, and tolerability of entrectinib capsule formulations F1 and F06 under fed conditions in healthy adult male and female participants.

Phase:

Phase 1

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Entrectinib